Charles River Labs Intl buy Barclays PLC
Start price
06.11.25
/
50%
€149.35
Target price
06.11.26
€182.47
Performance (%)
5.36%
Price
05.06.26
€157.35
Summary
This prediction is currently active. With a performance of 5.36%, the BUY prediction by Barclays_PLC for Charles River Labs Intl is trending in the right direction. This prediction currently runs until 06.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 1.549% | 1.549% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Barclays_PLC for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€151.30
08.05.26
08.05.26
-
08.05.27
08.05.27
4.56%
05.06.26
05.06.26
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.30
02.10.25
02.10.25
€166.12
02.10.26
02.10.26
5.39%
05.06.26
05.06.26